293 articles
Caron Jacobson, MD, Clinical Director, Immune Effector Cell Therapy Program, Dana-Farber Cancer Institute discusses the blood cancers lymphoma and leuke...
Courtney DiNardo of the MD Anderson Cancer Center discusses the difficult to treat acute myeloid leukemia (AML). She shares findings from the phase 3 ...
Andrew (Andy) Krivoshik, MD, Ph.D., SVP, and Oncology Therapeutic Head for Astellas Oncology shares his perspective on this year's C3 Prize (Changing Ca...
Returning guest, Bill Rancic discusses his ongoing partnership with the Astellas Oncology C3 Prize (Changing Cancer Care) program. The C3 Prize is a g...
Abby Westerman, founder of the b-present Foundation, winner of the Astellas Oncology 2019 C3 Prize (Changing Cancer Care) Emerging Ideas Winner, discuss...
The Nanny Angel Network in Canada was the grand prize winner of the Astellas Oncology 2019 C3 Prize (Changing Cancer Care). Audrey Guth, Founder of th...
Returning guest, Daniel Simon, SVP, BioPharma Business Development at Guardant Health, a leading precision oncology company discusses a strategic collab...
Gwen Nichols, M.D., Chief Medical Officer at the Leukemia & Lymphoma Society discusses blood cancers, the progress in blood cancer therapies, and the im...
David Spetzler, President and Chief Scientific Officer at Caris® Life Sciences discusses partnering with Merus, a clinical-stage oncology company, to d...
Kathryn Lang, vice president of Health Outcomes and Evidence at Guardant Health discusses research highlighting the significance of its LUNAR-2 liquid b...